El año pasado, Retractable Technologies Inc generó 24.91M USD en su segmento con mejor rendimiento, Syringes. United States realizó la mayor aportación, representando 32.24M USD el año pasado. Para el último trimestre, Retractable Technologies Inc reportó unos ingresos de 6.25M USD para el periodo finalizado el 2026-06-30, procedentes del segmento con mejor rendimiento, Syringes. United States aportó los mayores ingresos, alcanzando los 5.87M USD.

Por negocio

Ingresos operativos

Proporción

Anual

Anual

Trimestral

Syringes

EasyPoint Needles

Blood Cllection Products

Other Products

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

Syringes

24.91M(65.10%)

22.63M(68.47%)

34.16M(78.34%)

86.74M(91.48%)

176.33M(93.60%)

68.73M(83.96%)

35.64M(85.27%)

28.27M(84.95%)

EasyPoint Needles

11.94M(31.21%)

8.95M(27.08%)

7.25M(16.63%)

4.67M(4.93%)

9.64M(5.12%)

9.63M(11.76%)

2.98M(7.13%)

3.41M(10.26%)

Blood Cllection Products

1.37M(3.58%)

1.43M(4.31%)

1.93M(4.42%)

2.95M(3.12%)

2.25M(1.19%)

2.36M(2.89%)

2.72M(6.50%)

1.42M(4.28%)

Other Products

43.63K(0.11%)

45.85K(0.14%)

266.27K(0.61%)

451.95K(0.48%)

167.56K(0.09%)

1.14M(1.39%)

464.05K(1.11%)

172.41K(0.52%)

Por región

Ingresos operativos

Proporción

Anual

Anual

Trimestral

United States

North and South America(excluding U.S)

Other International

Sales to U.S. government

HHS Order sales to U.S. Government

North and South America sales

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

FY2011

United States

32.24M(84.24%)

29.37M(88.88%)

34.60M(79.36%)

36.49M(38.49%)

53.89M(28.61%)

42.17M(51.51%)

31.90M(76.32%)

28.65M(86.09%)

27.02M(78.32%)

26.31M(88.20%)

23.03M(77.93%)

27.65M(80.10%)

24.84M(80.70%)

25.36M(75.39%)

26.66M(83.03%)

North and South America(excluding U.S)

5.06M(13.22%)

1.96M(5.93%)

6.09M(13.96%)

29.13M(30.72%)

14.56M(7.73%)

6.89M(8.42%)

8.25M(19.74%)

3.60M(10.81%)

--(--)

Other International

968.61K(2.53%)

1.71M(5.19%)

2.91M(6.68%)

13.47M(14.20%)

6.27M(3.33%)

1.17M(1.42%)

1.65M(3.95%)

1.03M(3.10%)

1.10M(3.18%)

776.87K(2.60%)

853.44K(2.89%)

1.22M(3.53%)

1.49M(4.84%)

3.61M(10.74%)

710.16K(2.21%)

Sales to U.S. government

--(--)

15.73M(16.59%)

113.66M(60.34%)

--(--)

HHS Order sales to U.S. Government

--(--)

31.63M(38.64%)

--(--)

North and South America sales

--(--)

6.38M(18.50%)

2.74M(9.19%)

5.67M(19.18%)

5.65M(16.37%)

4.45M(14.47%)

4.67M(13.88%)

4.74M(14.75%)